Trial intelligence / Profile preview

g-RAMPP: Radical Prostatectomy in Pauci-metastatic Prostate Cancer

NCT02454543Active, not recruiting

Sponsor
Martini-Klinik
Start
May 2015
Primary completion
Dec 2019
Countries
1
01

Overview

Randomised, open-label trial in prostate cancer (PCa) (2 arms), sponsored by Martini-Klinik. Primary endpoint: Cancer specific survival at 10 years. Started May 2015; status: active, not recruiting.

02

Conditions

prostate cancer (PCa)

Beyond the preview

Go deeper on NCT02454543.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02454543.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call